BOTHELL, Wash., June 11 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it completed certification for its HeartCentrix(R) ECG informatics software with the Allscripts Electronic Health Record (EHR).
"Allscripts is a major player in electronic health systems, with more than 40,000 physician clients in some 5,000 health organizations ranging from solo doctors' offices to acute care hospitals. Physicians using Allscripts can now connect to Burdick(R) and Quinton(R) brand ECG devices, cardiac stress systems, Holter devices, and more," said Tony Titus, vice president of marketing, Cardiac Science. "By allowing diagnostic data from our products to flow seamlessly to the Allscripts EHR, this partnership makes both our companies' product offerings more attractive to the markets we serve."
The connectivity between Cardiac Science's equipment and the Allscripts EHR will help physicians streamline the diagnostic cardiology workflow in their offices, eliminate a source of data transcription errors, and provide a unified view of patient diagnostic data. With HeartCentrix ECG informatics, physicians will have immediate access to view or edit a patient's test results electronically and later retrieve the data from the Electronic Health Record.
Cardiac Science connects to Allscripts via the company's Universal Application Integrator (UAI), an innovative application that enables certified device vendors to quickly and easily connect to Allscripts Electronic Health Records.
"This is a big win for Allscripts and Cardiac Science, as well as for
our customers," said Steven Tolle, Vice President of Product Management for
Allscripts Clinical Solutions Group. "With HeartCentrix achieving UAI
certification, clinicians using Cardiac Science equipment can now improve
patient care and safety by integrating their devices with our Electronic
Company Contact: Investor Contact: Media Contact:
Mike Matysik Jenifer Kirtland Christopher Gale
Cardiac Science EVC Group, Inc. EVC Group, Inc.
Corporation (415) 896-6820 (201) 646-5431
Sr. Vice President (203) 570-4681
and CFO email@example.com
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com .
This press release contains forward-looking statements including, but not limited to, those that infer that Cardiac Science Corporation's future revenue and profits may increase as a result of the connectivity of its products with Allscripts' products. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks that are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2007. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
|SOURCE Cardiac Science Corporation|
Copyright©2008 PR Newswire.
All rights reserved